These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37385820)

  • 1. The complement system in IgAN: mechanistic context for therapeutic opportunities.
    Duval A; Caillard S; Frémeaux-Bacchi V
    Nephrol Dial Transplant; 2023 Nov; 38(12):2685-2693. PubMed ID: 37385820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA nephropathy: the lectin pathway and implications for targeted therapy.
    Barratt J; Lafayette RA; Zhang H; Tesar V; Rovin BH; Tumlin JA; Reich HN; Floege J
    Kidney Int; 2023 Aug; 104(2):254-264. PubMed ID: 37263354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complement in IgA nephropathy.
    Tortajada A; Gutierrez E; Pickering MC; Praga Terente M; Medjeral-Thomas N
    Mol Immunol; 2019 Oct; 114():123-132. PubMed ID: 31351413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
    Roos A; Rastaldi MP; Calvaresi N; Oortwijn BD; Schlagwein N; van Gijlswijk-Janssen DJ; Stahl GL; Matsushita M; Fujita T; van Kooten C; Daha MR
    J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of secretory IgA and complement in IgA nephropathy.
    Oortwijn BD; Eijgenraam JW; Rastaldi MP; Roos A; Daha MR; van Kooten C
    Semin Nephrol; 2008 Jan; 28(1):58-65. PubMed ID: 18222347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy.
    Rajasekaran A; Green TJ; Renfrow MB; Julian BA; Novak J; Rizk DV
    Drugs; 2023 Nov; 83(16):1475-1499. PubMed ID: 37747686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function.
    Onda K; Ohsawa I; Ohi H; Tamano M; Mano S; Wakabayashi M; Toki A; Horikoshi S; Fujita T; Tomino Y
    BMC Nephrol; 2011 Nov; 12():64. PubMed ID: 22111871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement Activation Is Associated With Crescents in IgA Nephropathy.
    Wang Z; Xie X; Li J; Zhang X; He J; Wang M; Lv J; Zhang H
    Front Immunol; 2021; 12():676919. PubMed ID: 34594322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation is associated with crescent formation in IgA nephropathy.
    Itami H; Hara S; Samejima K; Tsushima H; Morimoto K; Okamoto K; Kosugi T; Kawano T; Fujiki K; Kitada H; Hatakeyama K; Tsuruya K; Ohbayashi C
    Virchows Arch; 2020 Oct; 477(4):565-572. PubMed ID: 32300880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular endothelial activation, C4d deposits and microangiopathy in immunoglobulin A nephropathy.
    Trimarchi H; Coppo R
    Nephrol Dial Transplant; 2021 Mar; 36(4):581-586. PubMed ID: 31755918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crucial Role of AIM/CD5L in the Development of Glomerular Inflammation in IgA Nephropathy.
    Takahata A; Arai S; Hiramoto E; Kitada K; Kato R; Makita Y; Suzuki H; Nakata J; Araki K; Miyazaki T; Suzuki Y
    J Am Soc Nephrol; 2020 Sep; 31(9):2013-2024. PubMed ID: 32611589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arteriolar C4d in IgA Nephropathy: A Cohort Study.
    Faria B; Canão P; Cai Q; Henriques C; Matos AC; Poppelaars F; Gaya da Costa M; Daha MR; Silva R; Pestana M; Seelen MA
    Am J Kidney Dis; 2020 Nov; 76(5):669-678. PubMed ID: 32439421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement system is overactivated in patients with IgA nephropathy after COVID-19.
    Guo WY; Wang GQ; Kong LQ; Sun LJ; Xu XY; Cheng WR; Dong HR; Cheng H
    Clin Immunol; 2024 Jun; 263():110232. PubMed ID: 38701960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the Lectin Pathway of the Complement System as a Novel Approach in the Management of IgA Vasculitis-Associated Nephritis.
    Selvaskandan H; Kay Cheung C; Dormer J; Wimbury D; Martinez M; Xu G; Barratt J
    Nephron; 2020; 144(9):453-458. PubMed ID: 32721954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.
    Rizk DV; Maillard N; Julian BA; Knoppova B; Green TJ; Novak J; Wyatt RJ
    Front Immunol; 2019; 10():504. PubMed ID: 30941137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA Nephropathy: Core Curriculum 2021.
    Pattrapornpisut P; Avila-Casado C; Reich HN
    Am J Kidney Dis; 2021 Sep; 78(3):429-441. PubMed ID: 34247883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in IgA nephropathy.
    Medjeral-Thomas NR; Cook HT; Pickering MC
    Semin Immunopathol; 2021 Oct; 43(5):679-690. PubMed ID: 34379175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on treatment of immunoglobulin A nephropathy.
    Zhang YM; Zhang H
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():62-67. PubMed ID: 30298661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
    Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
    Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.